The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.
Because English is such a funny language!
India has airlifted more than 6 million COVID-19 doses to nine countries in Phase-I under its initiative termed "Vaccine Maitri".
Professor Chintamani Nagesa Ramachandra Rao is the third scientist to be awarded the highest civilian award -- Bharat Ratna, a crowning glory of his inexorable list of outstanding achievements.
Satya Nadella is the highest-paid CEO in the US. So how do the other Indian-American executives fare?
Sunak announced that the Immigration Health Surcharge (IHS) would be hiked from 400 pounds to 624 pounds.
Over 200 teachers from across India and abroad have written to Delhi University's vice-chancellor asking him to revoke Professor G N Saibaba's suspension so that he can rejoin his college.
Regulations ensure only PGs from Indian universities qualify.
The health ID will contain information about medical data, prescriptions and diagnostic reports and summaries of previous discharge from hospitals for ailments. The mission is expected to bring efficiency and transparency in healthcare services in the country.
'Prevention plus vaccination is what is going to take us into better territory by September or October.'
The course will help you turn your thoughts and ideas into short, meaningful essays and polish them for publishing or for blog posting.
Beauty is woven into the ghazal with such deep feelings of love that the focus is always on seeking oneness with the other, notes Gopi Chand Narang.
Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.
'You have sufficient protection if you take the second dose of the Covishield vaccine at 12 weeks, because this vaccine works in a way where it provides protection in the first dose.'
Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, minister of state for health Ashwini Choubey informed the Rajya Sabha on Tuesday.
Novelist Renu Balakrishnan will conduct a workshop for budding writers in April and March 2017.
'He came back from the US only to work for his country.' 'He has invested his fortunes to build this company and is married to his work.' 'Rarely does one see such commitment.'
The aim of the mission is to accelerate the development of at least six vaccine candidates and ensure that they are licenced and introduced in market for emergency use at the earliest.
'Since the NDA took office in 2014, and aggressively since 2019, the Union government seems hell bent on centralising all power and resources, only to fail spectacularly.'
Novelist Renu Balakrishnan will conduct a workshop for budding writers in January and February 2017 at the Xavier Institute of Communication, Mumbai.
Now you can order a drink with your face on it.
Alas, the 'basic income' schemes that have hit the headlines in the recent past are a far cry from the genuine article in terms of coverage and fiscal implications, says Vijay Joshi.
Cristiano Ronaldo has patched up his rift with Sepp Blatter following the FIFA president's hairdresser jibe and apparent imitation of the Portuguese international.
The prime minister wrote on Twitter, 'Sir VS Naipaul will be remembered for his extensive works, which covered diverse subjects ranging from history, culture, colonialism, politics and more.'
The first task before him is to get used to the idea of working with the Monetary Policy Committee
Over time, as more mutations occur, the vaccine may need to be altered.
Communications between the USTR and the world's most powerful pharmaceutical and trade lobbying groups reveal that many raised concerns about India's push to exempt Covid vaccines from intellectual property.
'The most intriguing thing (about COVID-19) is the range of the illness -- from asymptomatic or less symptoms to death and quite severe manifestations.' 'The vaccine will be at least another year away from having any effect.'
While Europe's rich culture and heritage may attract you, the American hype cannot be ignored too.
Scientists around the world, including in India, suggest it hasn't been tested properly given the time constraint and there may not be enough evidence to prove its efficacy.
An ardent backer of Brexit, Boris Johnson has a reputation for brashness, bombast, bending the truth, and really bad hair, which has earned him more than a few comparisons to United States President Donald Trump (who also happens to be a fan of his). Here are some interesting facts about BoJo, as he is called by the British media.
After healthcare and frontline workers, priority will be given to those above 50 years of age and the under-50 population groups with co-morbidities numbering around 27 crore, it added.
'The people of India have not only challenged the ruling dispensation with the constitution, they have also opened the eyes of the leadership that sits in the Opposition.'
Here's your weekly digest of the craziest and funniest stories from around the world.
What the UK is getting out of the Serum Institute is what India is losing. And the responsibility of the Indian State ought to have been to dictate where Serum Institute's vaccine doses should go, argues Ambassador M K Bhadrakumar.
The pieces will be made in China using the world'sbiggest 3D printer and then assembled in place in TrafalgarSquare in London and Times Square in New York.
Malala was dressed in Pakistani salwar kameez and dupatta. She was smiling and looked happy as he was greeted at the airport.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances